Art-No.: A-1169
Date: 10-12 March 2020
Price: EUR 380,-
No. | Topic | Summary | Pages |
14210 | Dossier Requirements for the Drug Substance | 0 | 33 |
14211 | Requirements for the certificate of Suitability | 0 | 45 |
14212 | Pharmaceutical Impurities: REsidual solvents, synthesis-derived and genotoxis impurities | 0 | 25 |
14213 | Stability data | 0 | 32 |
14214 | Workshop: Stability studies and estabilishing the restest-date | 0 | 14 |
14215 | Workshop: Description of the manufacturing process | 0 | 30 |
14216 | Workshop: Top Ten deficiences in new applications for certificates of Suitability for chemical purity | 0 | 55 |
14218 | APIs Regulatory staring materials | 0 | 33 |
14219 | Comparison od the CEP and DMF Procedure | 0 | 29 |
14220 | Variations/Changes and life cycle management in the EU, US and rest of the world | 0 | 42 |
14221 | Registration requirements for APIs in emerging countries | 0 | 33 |
14652 | How to read and use a CEP | 0 | 55 |
14653 | Pharmaceutical Impurities | 0 | 41 |
14654 | Registration procedures in the US and Japan | 0 | 42 |
14655 | The EDQM inspection program | 0 | 26 |
14656 | ICH Q3D - how to do in practice for APIs | 0 | 40 |
14805 | The European Active Substance Master File Procedures | 0 | 46 |